Patents by Inventor Beth Ann Wolf

Beth Ann Wolf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Low-temperature synthesis of thymoquinone and harmaline compounds
    Patent number: 12419872
    Abstract: Low-temperature syntheses of thymoquinone/harmaline compounds which are useful for the treatment of human diabetes and cancers, and the derivatives, solvates, prodrugs, isomers, and tautomers of such compounds.
    Type: Grant
    Filed: February 11, 2022
    Date of Patent: September 23, 2025
    Assignee: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Rachel Elizabeth Ropp, Krishna Mohan Donavalli, Rajni Verma
  • Topical medicaments
    Patent number: 11484492
    Abstract: Topical medicaments for the treatment of mammalian skin are provided, which include an actives fraction and a carrier fraction; the actives fraction comprises individual amounts of turmeric, Peganum harmala, and Arum palaestinum. In other embodiments, the actives fraction includes additional ingredients, including Vitamin C, ?-sitosterol, and vanillin compound(s). The medicaments are useful in the treatment of a wide variety of conditions.
    Type: Grant
    Filed: April 20, 2020
    Date of Patent: November 1, 2022
    Assignee: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Robert Preston Moore, Rachel Elizabeth Ropp
  • Low-temperature synthesis of thymoquinone and harmaline compounds
    Patent number: 11358963
    Abstract: Low-temperature syntheses of thymoquinone/harmaline compounds are provided which give increased yields of desirable products having molecular weights of from about 360-380. The syntheses involve carrying out reactions between thymoquinone and harmaline and a non-interfering solvent at a temperature of less than about 10° C.
    Type: Grant
    Filed: March 5, 2020
    Date of Patent: June 14, 2022
    Assignee: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Rachel Elizabeth Ropp
  • FORMULATIONS INHIBITING SARS-CoV-2 VIRUS
    Publication number: 20220175869
    Abstract: The treatment of human subjects exposed to, or potentially exposed to SARS-CoV-2 virus, or suffering from COVID-19, comprises the step of administering to the human subjects a formulation comprising turmeric, Peganum harmala, and Arum palaestinum, and/or variants thereof. Methods of inhibiting SARS-CoV-2 viral replication are also described.
    Type: Application
    Filed: December 2, 2021
    Publication date: June 9, 2022
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Robert Preston Moore, Larry D. Crow, Jason H. West
  • INHIBITION OF SARS-CoV-2 VIRUS BY ARUM PALAESTINUM
    Publication number: 20220175868
    Abstract: The treatment of human subjects exposed to, or potentially exposed to SARS-CoV-2 virus, or suffering from COVID-19, comprises the step of administering to the human subjects a formulation comprising Arum spp., particularly Arum palaestinum. Methods of inhibiting SARS-CoV-2 viral replication are also disclosed comprising contacting the virus with an Arum formulation.
    Type: Application
    Filed: December 2, 2021
    Publication date: June 9, 2022
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Robert Preston Moore, Larry D. Crow, Jason H. West
  • LOW-TEMPERATURE SYNTHESIS OF THYMOQUINONE AND HARMALINE COMPOUNDS
    Publication number: 20220160685
    Abstract: Low-temperature syntheses of thymoquinone/harmaline compounds which are useful for the treatment of human diabetes and cancers, and the derivatives, solvates, prodrugs, isomers, and tautomers of such compounds.
    Type: Application
    Filed: February 11, 2022
    Publication date: May 26, 2022
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Rachel Elizabeth Ropp, Krishna Mohan Donavalli, Rajni Verma
  • Nutritional supplement for mammals
    Patent number: 11246902
    Abstract: Mammalian nutritional supplements comprising individual quantities of turmeric, Peganum harmala, and Arum palaestinum are provided, which promote several aspects of human health, and canine health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum, and the supplements may contain additional beneficial ingredients, such as ?-sitosterol, vanillin, garlic, and Vitamin C.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: February 15, 2022
    Assignee: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Larry D. Crow, Robert Preston Moore, Rachel Elizabeth Ropp
  • LOW-TEMPERATURE SYNTHESIS OF THYMOQUINONE AND HARMALINE COMPOUNDS
    Publication number: 20210276998
    Abstract: Low-temperature syntheses of thymoquinone/harmaline compounds are provided which give increased yields of desirable products having molecular weights of from about 360-380. The syntheses involve carrying out reactions between thymoquinone and harmaline and a non-interfering solvent at a temperature of less than about 10° C.
    Type: Application
    Filed: March 5, 2020
    Publication date: September 9, 2021
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Rachel Elizabeth Ropp
  • TOPICAL MEDICAMENTS
    Publication number: 20200330372
    Abstract: Topical medicaments for the treatment of mammalian skin are provided, which include an actives fraction and a carrier fraction; the actives fraction comprises individual amounts of turmeric, Peganum harmala, and Arum palaestinum. In other embodiments, the actives fraction includes additional ingredients, including Vitamin C, ?-sitosterol, and vanillin compound(s). The medicaments are useful in the treatment of a wide variety of conditions.
    Type: Application
    Filed: April 20, 2020
    Publication date: October 22, 2020
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Robert Preston Moore, Rachel Elizabeth Ropp
  • Nutritional supplement
    Patent number: 10772347
    Abstract: Nutritional supplements comprising individual quantities of turmeric, Peganum harmala, and Arum palaestinum are provided, which promote several aspects of human health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum, and the supplements may contain additional beneficial ingredients, such as ?-sitosterol, vanillin, garlic, and Vitamin C.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: September 15, 2020
    Assignee: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Larry D. Crow
  • NUTRITIONAL SUPPLEMENT
    Publication number: 20190269166
    Abstract: Nutritional supplements comprising individual quantities of turmeric, Peganum harmala, and Arum palaestinum are provided, which promote several aspects of human health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum, and the supplements may contain additional beneficial ingredients, such as ?-sitosterol, vanillin, garlic, and Vitamin C.
    Type: Application
    Filed: May 22, 2019
    Publication date: September 5, 2019
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Larry D. Crow
  • NUTRITIONAL SUPPLEMENT
    Publication number: 20190261667
    Abstract: Nutritional supplements comprising individual quantities of turmeric, Peganum harmala, and Arum palaestinum are provided, which promote several aspects of human health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum, and the supplements may contain additional beneficial ingredients, such as ?-sitosterol, vanillin, garlic, and Vitamin C.
    Type: Application
    Filed: August 28, 2018
    Publication date: August 29, 2019
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Larry D. Crow
  • NUTRITIONAL SUPPLEMENT FOR MAMMALS
    Publication number: 20190262416
    Abstract: Mammalian nutritional supplements comprising individual quantities of turmeric, Peganum harmala, and Arum palaestinum are provided, which promote several aspects of human health, and canine health. Advantageously, the turmeric is present in an amount greater than that of Peganum harmala or Arum palaestinum, and the supplements may contain additional beneficial ingredients, such as ?-sitosterol, vanillin, garlic, and Vitamin C.
    Type: Application
    Filed: February 20, 2019
    Publication date: August 29, 2019
    Applicant: Ankh Life Sciences Limited
    Inventors: Gene H. Zaid, Beth Ann Wolf, Larry D. Crow, Robert Preston Moore, Rachel Elizabeth Ropp
  • Poly alkanolamine emulsion breakers
    Patent number: 9701791
    Abstract: Poly alkanolamines formed as the reaction products of secondary or tertiary alkanolamines, C8-C24 fatty acids, and shorter chain organic acids are provided, which serve as excellent petroleum/water emulsion breakers for water-in-oil emulsions and reverse oil-in-water emulsions. The polymers are preferably prepared using a reaction mixture of triethanolamine, tall oil fatty acids, and acetic acid.
    Type: Grant
    Filed: August 18, 2016
    Date of Patent: July 11, 2017
    Assignee: Jacam Chemical Company 2013, LLC
    Inventors: David Jay Rose, Thomas Joseph Fortune, Thomas W. Burgoyne, Kim Brashear, Beth Ann Wolf, Gene H. Zaid
  • Emulsified polyol acrylate polymeric emulsion breakers
    Patent number: 9701830
    Abstract: Improved emulsion breakers in the form of polyol acrylate polymers in water/oil emulsions have relatively high polymer contents and low inversion viscosities. The emulsion breakers can be prepared by mixing together acrylate monomer, polyol, water, liquid petroleum product, and emulsifier, followed by homogenization of the mixture; the latter is then subjected to free radical polymerization to polymerize the polyol and monomer in situ within the mixture.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: July 11, 2017
    Assignee: Jacam Chemical Company 2013, LLC
    Inventors: David Jay Rose, Thomas Joseph Fortune, Thomas W. Burgoyne, Kim Brashear, Beth Ann Wolf, Gene H. Zaid
  • POLY ALKANOLAMINE EMULSION BREAKERS
    Publication number: 20170066881
    Abstract: Poly alkanolamines formed as the reaction products of secondary or tertiary alkanolamines, C8-C24 fatty acids, and shorter chain organic acids are provided, which serve as excellent petroleum/water emulsion breakers for water-in-oil emulsions and reverse oil-in-water emulsions. The polymers are preferably prepared using a reaction mixture of triethanolamine, tall oil fatty acids, and acetic acid.
    Type: Application
    Filed: August 18, 2016
    Publication date: March 9, 2017
    Applicant: Jacam Chemical Company 2013, LLC
    Inventors: David Jay Rose, Thomas Joseph Fortune, Thomas W. Burgoyne, Kim Brashear, Beth Ann Wolf, Gene H. Zaid
  • Oil-soluble triazine sulfide scavenger
    Patent number: 8512449
    Abstract: The present invention is directed to water-dispersible, oil-soluble triazine sulfide-scavenging compositions for use in hydrocarbon recovery and processing applications. The compositions include a triazine component, a glycol ether component, and an optional alcohol component. The compositions contain a minor amount of water up to a maximum of about 15% by volume. The compositions can be used in any type of sulfide-scavenging operation and significantly reduce corrosion problems found with conventional triazine scavengers.
    Type: Grant
    Filed: December 3, 2010
    Date of Patent: August 20, 2013
    Assignee: Jacam Chemical Company 2013, LLC
    Inventors: Gene H. Zaid, Beth Ann Wolf
  • Method of removing arsenic from hydrocarbons
    Patent number: 8241491
    Abstract: Improved methods for removing arsenic from starting liquid hydrocarbons are provided which comprise contacting the hydrocarbons with a composition containing a triazine component and a glycol ether component, allowing the composition to react with the arsenic to create a treated hydrocarbon fraction and an arsenic-rich fraction, and separating the treated fraction from the arsenic-rich fraction. Preferably, the treating composition also includes an alcohol, and is used at a level of from about 1-10,000 ppm.
    Type: Grant
    Filed: October 1, 2011
    Date of Patent: August 14, 2012
    Assignee: JaCam Chemicals, LLC
    Inventors: Gene H. Zaid, Beth Ann Wolf
  • Method of removing arsenic from hydrocarbons
    Patent number: 8211294
    Abstract: Improved methods for removing arsenic from starting liquid hydrocarbons are provided which comprise contacting the hydrocarbons with a composition containing a triazine component and a glycol ether component, allowing the composition to react with the arsenic to create a treated hydrocarbon fraction and an arsenic-rich fraction, and separating the treated fraction from the arsenic-rich fraction. Preferably, the treating composition also includes an alcohol, and is used at a level of from about 1-10,000 ppm.
    Type: Grant
    Filed: March 21, 2012
    Date of Patent: July 3, 2012
    Assignee: JaCam Chemicals, LLC
    Inventors: Gene H. Zaid, Beth Ann Wolf
  • METHODS AND DOSAGE FORMS FOR THE TREATMENT OF HUMAN CANCERS
    Publication number: 20120108556
    Abstract: Methods for the treatment of human cancers, daily dosage forms for cancer patients, and methods of formulating the dosage forms are provided wherein the daily dosage form contains from about 10-6,000 mg of each of ?-sitosterol, isovanillin, and linolenic acid. Preferably, the dosage forms are formulated by first creating an aqueous decoction of Arum palaestinum Boiss, followed by fortification of the decoction with additional quantities of ?-sitosterol, isovanillin, and linolenic acid.
    Type: Application
    Filed: January 11, 2012
    Publication date: May 3, 2012
    Applicant: Life Plus, LLC
    Inventors: Gene H. Zaid, Thomas W. Burgoyne, Beth Ann Wolf